Overview
Biosimilars are biologic medications that are highly similar to an existing approved biologic drug (the reference product). They are designed to have the same efficacy and safety as the reference product, but at a potentially lower cost. Biosimilars offer an alternative treatment option for certain skin conditions, providing patients with increased access to effective therapies.
What are biosimilars?
Biosimilars are developed through a complex process that involves comparing the biosimilar with the reference product to demonstrate similarity in terms of structure, function, and clinical efficacy. The regulatory authorities carefully evaluate the data to ensure the biosimilar is comparable to the reference product and can be safely used.